Selcuk Ecza Deposu

What Selcuk Ecza Deposu does

Selcuk Ecza Deposu is a publicly listed Turkish pharmaceutical wholesale distributor (BIST: SELEC) founded in 1958 by Dr. Ahmet Keleşoğlu and headquartered in Pendik, Istanbul. The company procures branded and generic pharmaceuticals from manufacturers and redistributes them through a network of 22+ regional branches to approximately 19,000 retail pharmacies nationwide, making it the largest pharmaceutical wholesaler in Turkey by revenue. A sister company, As Ecza Deposu, and a foundation (Ahmet ve Nezahat Keleşoğlu Vakfı) sit alongside the operating business, with ultimate ownership held through Selcuk Ecza Holding A.S., chaired by M. Sonay Gürgen.

The company's technology layer is built around pharmacy workflow integration rather than consumer-facing software. WebDepo is a B2B ordering portal, while E-Arşiv Fatura (electronic archiving invoice) is the mandatory billing integration tied to Turkish tax regulation. Order capture is automated through integrations with multiple third-party pharmacy management systems (including Farmakom and Bayt), drug/price/barcode lookup is exposed to pharmacy users, and the İlaç Takip Sistemi (İTS) integration handles regulatory drug tracking. Annual sales events held in 6+ cities bring together 100+ manufacturers and 5,000+ pharmacists, functioning as both a commercial and relationship-maintenance channel.

The business model is classic pharma wholesale: buy from manufacturers at contracted terms, distribute to pharmacies on short credit cycles, and earn spread on volume. Reported financials show nominal revenue of approximately ₺172 billion in 2025 (versus ₺168 billion in 2024, ₺141 billion in 2023, and ₺85 billion in 2022), with EBITDA of �3.3 billion in 2025 versus ₺8.2 billion in 2024 and a swing from ₺2.7 billion net income in 2024 to a ₺380 million net loss in 2025, indicating significant margin pressure despite stable headline revenue. Customer base is broad across ~19,000 SMB pharmacy accounts with no individually material customer concentration.

Name

Selcuk Ecza Deposu

Legal name

Selçuk Ecza Deposu Ticaret ve Sanayi A.Ş.

Website

https://selcukecza.com.tr

Company type

Private

Founded year

1958

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

Selcuk Ecza Deposu is Turkey's largest pharmaceutical wholesale distributor, founded 1958, procuring from 100+ manufacturers and redistributing to ~19,000 retail pharmacies through 22+ regional branches and digital ordering/invoicing integrations.

Ownership category

akta.pro rank

Product category

Pharmaceutical Wholesale Distribution

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Full-Line Pharmaceutical Wholesalers (HLAIAJAA)

akta.pro secondary industries

Hospital & Health-System Pharmaceutical Distributors (HLAIAJAD), Fragrance & Deodorant Distribution (CRAOAEAF)

Keywords

• Pharmaceutical wholesale distribution
• Drug distribution services
• Pharmacy supply chain
• Healthcare logistics services
• Pharmaceutical B2B distribution

Headquarters

HQ city

Pendik

Offices24 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Supply Chain, Operations, Infrastructure, Personnel, Marketing or Sales, Technology or R&D

Revenue model

1. Pharmaceutical Wholesale Distribution: Selcuk Ecza Deposu generates revenue by purchasing pharmaceutical products from manufacturers and distributors and reselling them to pharmacies (eczane) across Turkey. As the sector leader, the company distributes the full range of prescription and OTC pharmaceuticals, functioning as the intermediary between the pharmaceutical industry and retail pharmacy network. The company also distributes non-pharmaceutical health and cosmetics (ıtriyat) products to pharmacies through organized sales events.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels5 records

Core offering

Selcuk Ecza Deposu is Turkey's leading pharmaceutical wholesale distributor, purchasing pharmaceutical products from manufacturers and reselling them to approximately 19,000 retail pharmacies across the country. The company operates 22+ regional branch warehouses covering all major Turkish cities, supported by a field sales force and the WebDepo B2B online ordering platform. It also distributes non-pharmaceutical health and cosmetics (itriyat) products through organized sales events.

Product overview

Selcuk Ecza Deposu operates as Turkey's leading pharmaceutical distribution company, offering a unified platform of digital services centered around WebDepo (web-based ordering), combined with consumer-facing tools including medicine price/barcode search, on-duty pharmacy finder, and price calculation utilities. The company also provides electronic invoice solutions (E-Arşiv Fatura) for pharmacy partners and maintains a pharmaceutical legislation repository. The core offering is the distribution of pharmaceutical products to pharmacies nationwide, supported by these digital service modules.

Differentiator

Problem solved

Functional benefit

Products and services

• WebDepo B2B Ordering Platform Web-based B2B pharmaceutical ordering platform that enables retail pharmacies across Turkey to place orders electronically, with separate login portals for sales representatives and company accounts.
• İlaç Fiyat ve Barkod Arama (Drug Price and Barcode Search) Online tool for searching medicine prices and barcodes, with downloadable Excel format price lists. Enables lookup by barcode, medicine name, company name, and date filters for pharmacists and industry participants.
• İlaç Fiyat Hesaplama (Medicine Price Calculator) Retail price calculation tool that computes wholesale prices, distributor prices, pharmacist margins, and VAT based on retail price input.
• Nöbetçi Eczaneler (On-Duty Pharmacy Finder) Regional on-duty pharmacy locator service covering multiple districts across Turkey, allowing consumers to find nearby open pharmacies by region selection.
• E-Arşiv Fatura (E-Archive Invoice System) Electronic archive invoice system that delivers invoices both physically with products and electronically via email, providing legal validity for both formats to pharmacy customers.
• İlaç ve Eczacılık Mevzuatı (Pharmaceutical Legislation Repository) Repository of pharmaceutical regulations and legislation, including Ministry of Health circulars on controlled substances and drug distribution tracking.
• Pharmaceutical Wholesale Distribution Core pharmaceutical wholesale distribution service that purchases pharmaceutical products from manufacturers and resells them to approximately 19,000 retail pharmacies across Turkey, including prescription drugs, OTC products, and non-pharmaceutical health and cosmetics (itriyat) items.

Quantifiable outcome

• Ranked #1 in the 'Pharmaceuticals and Distribution' sector in Capital 500 research, 2025
• +3 more outcomes

Named customers2 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration8 records

Feature5 records

Partnerships

Four partnerships are on record, tiered core and minor.

• AS Ecza Deposu (A.Ş.)coreOthersAS Ecza Deposu is the sister company of Selcuk Ecza Deposu under the Selcuk Ecza Holding corporate umbrella. Both companies operate in the pharmaceutical distribution sector, share management (Y.K. Başkanı M. Sonay Gürgen leads both), and jointly organize events such as the annual Satış Etkinliği, Selcuk-As Ecza Akademisi professional development programs, and the 60th anniversary celebrations. The two companies function as a unified distribution network, each serving different geographic territories or customer segments.
• Farmazi AkademicoreStrategic or Co-development PartnerFarmazi Akademi is the academic partner for the Selcuk-As Ecza Akademisi professional development program. The academy provides continuing education for pharmacists including scientific updates, pharmacy business management, and industry trends. The partnership enables the company to deliver structured professional development across multiple cities in Turkey, strengthening customer relationships with the pharmacy network.
• World Health Organization (WHO)minorOthersWHO visited Selcuk Ecza's Izmir branch to review and assess pharmaceutical cold chain practices, drug distribution integrity, and automation systems. This external validation by a leading international health authority confirms the company's compliance with global best practices in pharmaceutical logistics.
• Ahmet ve Nezahat Keleşoğlu Vakfı (ANK Foundation)coreOthersThe Ahmet ve Nezahat Keleşoğlu Vakfı is the charitable foundation established by the founder family of Selcuk Ecza Holding. The foundation focuses on education, healthcare, culture, and arts, having donated over ₺70 million to educational initiatives. It sponsors cultural projects including the Ahmet Keleşoğlu Arkeoloji ve Etnografya Müzesi (opened June 2026), Ahmet Keleşoğlu Kent Müzesi, and university faculties. The foundation enhances Selcuk Ecza's brand reputation through CSR activities.

Scale indicators11 records

Recent moves10 records

Expansion highlights4 records

Broad incumbents

• Walgreens Boots Alliance: Global pharmacy and wholesale distribution operator with a large retail pharmacy footprint and pharmaceutical wholesale operations. Comparable to Selçuk Ecza on the pharmacy distribution and retail-pharmacy relationship dimensions.
• Cardinal Health: Major US-headquartered pharmaceutical distributor with global wholesale operations serving retail pharmacies, hospitals, and health systems. Comparable to Selçuk Ecza as a scaled pharma wholesaler with integrated digital ordering and regulatory tracking.
• McKesson Corporation: Largest pharmaceutical distributor in North America, operating a global wholesale distribution platform serving pharmacies, hospitals, and health systems. Comparable to Selçuk Ecza as a scaled pharma wholesaler, though operating in much larger and more diversified geographies.
• Cencora (AmerisourceBergen): One of the largest global pharmaceutical solutions companies, distributing drugs to pharmacies, hospitals, and healthcare providers worldwide. Relevant as a global full-line pharmaceutical wholesaler comparable in business model to Selçuk Ecza's wholesale distribution operations.
• PHOENIX Group (PHOENIX Pharmahandel): Leading European pharmaceutical distribution group operating across ~30 countries, with retail pharmacy and wholesale operations. Comparable as a continent-spanning full-line pharma wholesaler with integrated pharmacy retail, contrasting with Selçuk Ecza's single-country model.

Direct peers

• Çetin Ecza Deposu: Turkish pharmaceutical wholesale distributor serving retail pharmacies with similar product mix, regional branch network, and B2B ordering model. Directly competes with Selçuk Ecza for the same ~19,000-pharmacy customer base.
• Hedef Alliance Holding: One of the largest pharmaceutical distribution groups in Turkey, formed via consolidation of multiple regional eczane deposu companies. Directly comparable to Selçuk Ecza as a competing full-line pharmaceutical wholesaler serving the Turkish pharmacy network.
• Polat Ecza Deposu: Regional Turkish pharmaceutical wholesale distributor serving retail pharmacies with similar full-line distribution model. Directly competes with Selçuk Ecza for Turkish pharmacy customers in overlapping geographies.
• AS Ecza Deposu: Wholly-owned sister company of Selçuk Ecza Deposu under Selçuk Ecza Holding, also distributing pharmaceuticals to Turkish pharmacies through branches in Adana, Denizli, Sancaktepe, and İzmir. Direct peer because it operates the same pharmaceutical wholesale model to the same pharmacy customer base with shared management.

Regional players

• Eczacıbaşı İlaç Pazarlama: Major Turkish healthcare/pharmaceutical marketing and distribution arm of the Eczacıbaşı Group, distributing pharma products within Turkey. Comparable as a domestic Turkish pharmaceutical distribution competitor serving overlapping pharmacy and hospital channels.

Market position

Strengths6 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Selcuk Ecza Deposu